Insulin-like growth factor 2 expression modulates taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer

1. Huang, G.S.
2. Brouwer-Visser, J.
3. Ramirez, M.J.
4. Kim, C.H.
5. Hebert, T.M.
6. Lin, J.
7. Arias-Pulido, H.
8. Qualls, C.R.
9. Prossnitz, E.R.
10. Goldberg, G.L.
11. Smith, H.O.
12. Horwitz, S.B.